This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove digital therapeutics Remove education Remove VC Related Topics
incumbents strategy opportunity support disruption development leadership sustainability investment investing More Related Topics >
article thumbnail

11 investors predict a colorful, if difficult, future for psychedelic startups

TechCrunch

MAY 12, 2023

In the meantime, pharma and big biotech VC firms are more interested in exploring the non-hallucinogenic psychedelic pathways. Additionally, a reliable source of information to educate individuals would be required. This requires proper education about psychedelics and safe protocols to follow.

startup 99
startup digital therapeutics health development 99
article thumbnail

Vira Health gets $12M to dial up personalized menopause support

TechCrunch

MARCH 14, 2022

startup that offers personalized digital therapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based based VC firm Optum Ventures, as it gears up to hop over the pond. Vira Health , a U.K.

health 86
health support digital therapeutics disruption 86
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
LinkedIn Twitter
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024